Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details)

v3.23.3
Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Common stock warrants        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 2,301,250 2,301,250 2,301,250 2,301,250
Earnout Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 438,800 438,800 438,800 438,800
Unvested RSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 568,570 655,882 568,570 655,882